Advertisement
Advertisement

PALI

PALI logo

Palisade Bio, Inc. Common Stock

2.11
USD
Sponsored
+0.02
+0.96%
Aug 07, 15:56 UTC -4
Closed
exchange

After-Market

2.10

-0.01
-0.71%

Palisade Bio, Inc. Common Stock Profile

About

Palisade Bio Inc. is a late-stage biopharma company advancing therapies which help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio Inc., formerly known as Seneca Biopharma Inc., is based in CARLSBAD, Calif.

Info & Links

CEO

J.D. Finley

Headquarters

4600 South Syracuse Street, Suite 900
Denver, CA 80237, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.palisadebio.com

Auditor

Baker Tilly US, LLP

Share holders

134

Employees

14

Palisade Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

364.07M

Enterprise Value

231.44M

Enterprise Value/EBITDA(ttm)

-8.74

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.77

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-36.79%

Return on Invested Capital(ttm)

-209.97%

Return on Assets(ttm)

-34.34%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-26.49M

Net Income Available to Common(ttm)

-24.15M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.52

52-Week Change

167.05%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

173.58M

Dividend Yield

0.00%

Float4

173.46M

% Held by Insiders

0.07%

% Held by Institutions

11.79%

Balance Sheet

Total Cash(mrq)

132.63M

Total Cash Per Share(mrq)

0.76

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

23.71%

Quick Ratio(mrq)

23.71%

Book Value Per Share(mrq)

0.76

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.02

Free Cash Flow(ytd)

-3.89M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement